摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

Boc-GGGG-OCH2Ph | 108432-90-2

中文名称
——
中文别名
——
英文名称
Boc-GGGG-OCH2Ph
英文别名
Boc-Gly4-OBzl;benzyl 2,2-dimethyl-4,7,10,13-tetraoxo-3-oxa-5,8,11,14-tetraazahexadecan-16-oate;Boc-(Gly)4-OBn;{2-[2-(2-tert-butoxycarbonylamino-acetylamino)-acetylamiono]-acetylamino}-acetic acid benzyl ester;Boc-Gly-Gly-Gly-Gly-OBn;benzyl 2-[[2-[[2-[[2-[(2-methylpropan-2-yl)oxycarbonylamino]acetyl]amino]acetyl]amino]acetyl]amino]acetate
Boc-GGGG-OCH2Ph化学式
CAS
108432-90-2
化学式
C20H28N4O7
mdl
——
分子量
436.465
InChiKey
VGVOUQMBYWKJIM-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    189-190 °C
  • 沸点:
    750.1±60.0 °C(Predicted)
  • 密度:
    1.233±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    0.4
  • 重原子数:
    31
  • 可旋转键数:
    13
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.45
  • 拓扑面积:
    152
  • 氢给体数:
    4
  • 氢受体数:
    7

SDS

SDS:f119280e2a87f2c35c623e4a198b0e33
查看

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    Boc-GGGG-OCH2Ph 在 palladium on activated charcoal 盐酸氢气三乙胺N,N'-二异丙基碳二亚胺 作用下, 以 1,4-二氧六环乙醇二氯甲烷 为溶剂, 5.0~20.0 ℃ 、413.68 kPa 条件下, 反应 76.0h, 生成 2-[[2-[[2-[[2-[[2-[2-(dioctadecylamino)-2-oxoethoxy]acetyl]amino]acetyl]amino]acetyl]amino]acetyl]amino]acetic acid
    参考文献:
    名称:
    Cation Dependence of Chloride Ion Complexation by Open-Chained Receptor Molecules in Chloroform Solution
    摘要:
    Seventeen peptides, most having the sequence GGGPGGG, but differing in the C- and N-terminal ends, have been studied as anion-complexing agents. These relatively simple, open-chained peptide systems interact with both chloride and the associated cation. Changes, in the N- and C-terminal side chains appear to make little difference in the efficacy of binding. NMR studies suggest that the primary interactions involve amide NH contacts with the chloride anion, and CD spectral analyses suggest a concomitant conformational change upon binding. Changes in binding constants, which are expected in different solvents, also suggest selective solvent interactions with the unbound host that helps to preorganize the open-chained peptide system. Significant differences are apparent in complexation strengths when the heptapeptide chain is shortened or lengthened or when the relative position of proline within the heptapeptide is varied.
    DOI:
    10.1021/ja0558894
  • 作为产物:
    描述:
    N-(tert-butoxycarbonyl)glycylglycine benzyl ester 在 palladium on activated charcoal N-甲基吗啉氢气N,N'-二环己基碳二亚胺 作用下, 以 甲醇二氯甲烷溶剂黄146 为溶剂, 生成 Boc-GGGG-OCH2Ph
    参考文献:
    名称:
    Conformations in the Solid State and Solubility Properties of Protected Homooligopeptides of Glycine and β-Alanine
    摘要:
    在固态下对Boc–Glyn–OBzl(n=3–7)和Boc–(β-Ala)n–OBzl(n=3–8)进行了红外光谱构象分析,结果表明较高聚体(n=5–8)中存在β-折叠结构。溶解度数据显示,Boc–Glyn–OBzl和Boc–(β-Ala)n–OBzl在高度极性溶剂中的不溶性分别从六肽和七肽水平开始。保护性同聚肽Gly和β-Ala的不溶性估计是由β-折叠聚集引起的。Boc–Glyn–OBzl和Boc–(β-Ala)n–OBzl(n≥5)形成β-折叠结构的高潜力可以明显归因于β-折叠结构中每个Gly和β-Ala残基肽骨架二面角的大自由度。还讨论了蛋白质表面区域中少量Gly残基被β-Ala残基替代的意义。
    DOI:
    10.1246/bcsj.59.3553
点击查看最新优质反应信息

文献信息

  • Synthesis of chimeric tetrapeptide-linked cholic acid derivatives: Impending synergistic agents
    作者:Sudhir N. Bavikar、Deepak B. Salunke、Braja G. Hazra、Vandana S. Pore、Robert H. Dodd、Josiane Thierry、Fazal Shirazi、Mukund V. Deshpande、Sreenath Kadreppa、Samit Chattopadhyay
    DOI:10.1016/j.bmcl.2008.09.013
    日期:2008.10
    Tetrapeptides derived from glycine and beta-alanine were hooked at the C-3 beta position of the modified cholic acid to realize novel linear tetrapeptide-linked cholic acid derivatives. All the synthesized compounds were tested against a wide variety of microorganisms (Gram-negative bacteria, Gram-positive bacteria and fungi) and their cytotoxicity was evaluated against human embryonic kidney (HEK293) and human mammary adenocarcinoma (MCF-7) cell lines. While relatively inactive by themselves, these compounds interact synergistically with antibiotics such as fluconazole and erythromycin to inhibit growth of fungi and bacteria, respectively, at 1-24 mu g/mL. The synergistic effect shown by our novel compounds is due to their inherent amphiphilicity. The fractional inhibitory concentrations reported are comparable to those reported for Polymyxin B derivatives. (c) 2008 Elsevier Ltd. All rights reserved.
  • [EN] ANTI-GLP1R ANTIBODY-DRUG CONJUGATES COMPRISING GLP1 PEPTIDOMIMETICS AND USES THEREOF<br/>[FR] CONJUGUÉS ANTICORPS-MÉDICAMENT ANTI-GLP1R COMPRENANT DES PEPTIDOMIMÉTIQUES DE GLP1 ET LEURS UTILISATIONS
    申请人:[en]REGENERON PHARMACEUTICALS, INC.
    公开号:WO2023173132A1
    公开(公告)日:2023-09-14
    The present invention provides antibody-tethered drug conjugates (ATDCs) and compositions thereof that are useful, for example, for targeting glucagon-like peptide 1 receptor (GLP1 R) and treating various conditions, e.g., diabetes. Methods for making such ATDCs are also provided along with method of use thereof.
  • Cation Dependence of Chloride Ion Complexation by Open-Chained Receptor Molecules in Chloroform Solution
    作者:Robert Pajewski、Riccardo Ferdani、Jolanta Pajewska、Ruiqiong Li、George W. Gokel
    DOI:10.1021/ja0558894
    日期:2005.12.1
    Seventeen peptides, most having the sequence GGGPGGG, but differing in the C- and N-terminal ends, have been studied as anion-complexing agents. These relatively simple, open-chained peptide systems interact with both chloride and the associated cation. Changes, in the N- and C-terminal side chains appear to make little difference in the efficacy of binding. NMR studies suggest that the primary interactions involve amide NH contacts with the chloride anion, and CD spectral analyses suggest a concomitant conformational change upon binding. Changes in binding constants, which are expected in different solvents, also suggest selective solvent interactions with the unbound host that helps to preorganize the open-chained peptide system. Significant differences are apparent in complexation strengths when the heptapeptide chain is shortened or lengthened or when the relative position of proline within the heptapeptide is varied.
  • Conformations in the Solid State and Solubility Properties of Protected Homooligopeptides of Glycine and β-Alanine
    作者:Mitsuaki Narita、Masamitsu Doi、Koji Kudo、Yusuke Terauchi
    DOI:10.1246/bcsj.59.3553
    日期:1986.11
    IR spectroscopic conformational analyses of Boc–Glyn–OBzl (n=3–7) and Boc–(β-Ala)n–OBzl (n=3–8) were performed in the solid state, suggesting the occurrence of the β-sheet structure in the higher oligomers (n=5–8). Solubility data indicate that insolubilities of Boc–Glyn–OBzl and Boc–(β-Ala)n–OBzl in high-polar solvents begin at hexa- and heptapeptide levels, respectively. Insolubility of protected homooligopeptides of Gly and β-Ala was estimated to be caused by β-sheet aggregation. The high potential for the β-sheet formation of Boc–Glyn–OBzl and Boc–(β-Ala)n–OBzl (n≥5) could clearly be attributed to the great freedom of the peptide backbone dihedral angles of each of the Gly and β-Ala residues in the β-sheet structure. The implications of a replacement of a few Gly residues with β-Ala residues in surface regions of proteins are also discussed.
    在固态下对Boc–Glyn–OBzl(n=3–7)和Boc–(β-Ala)n–OBzl(n=3–8)进行了红外光谱构象分析,结果表明较高聚体(n=5–8)中存在β-折叠结构。溶解度数据显示,Boc–Glyn–OBzl和Boc–(β-Ala)n–OBzl在高度极性溶剂中的不溶性分别从六肽和七肽水平开始。保护性同聚肽Gly和β-Ala的不溶性估计是由β-折叠聚集引起的。Boc–Glyn–OBzl和Boc–(β-Ala)n–OBzl(n≥5)形成β-折叠结构的高潜力可以明显归因于β-折叠结构中每个Gly和β-Ala残基肽骨架二面角的大自由度。还讨论了蛋白质表面区域中少量Gly残基被β-Ala残基替代的意义。
查看更多

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸 麦撒奎 鹅膏氨酸 鹅膏氨酸 鸦胆子酸A甲酯 鸦胆子酸A 鸟氨酸缩合物